Associations of residential walkability and greenness with arterial stiffness in the UK Biobank by Lai, KY, Kumari, S, Gallacher, J, Webster, C, Sarkar, C

“…Methods We employed data from the baseline UK Biobank cohort comprising adult participants recruited over the period of 2006 to 2010. …”

A scoping review of considerations and practices for benefit sharing in biobanking by Sudoi, A, De Vries, J, Kamuya, D

“…<br><strong>Background<br></strong> Despite the rapid global growth of biobanking over the last few decades, and their potential for the advancement of health research, considerations specific to the sharing of benefits that accrue from biobanks have received little attention. …”

Diet and colorectal cancer in UK Biobank: a prospective study by Bradbury, K, Murphy, N, Key, T

“…</p> <p><strong>METHODS:</strong> We used Cox-regression models to estimate adjusted hazard ratios for colorectal cancer by dietary factors in the UK Biobank study. Men and women aged 40-69 years at recruitment (2006-10) reported their diet on a short food-frequency questionnaire (n = 475 581). …”

Collecting and Consulting Publics: Constituting natural and ethical orders in biobanking by Hinterberger, A

The relationship between isolated hypertension with brain volumes in UK Biobank by Newby, D, Winchester, L, Sproviero, W, Fernandes, M, Ghose, U, Lyall, D, Launer, LJ, Nevado-Holgado, AJ

“…<p><strong>Methods</strong></p> Using the UK Biobank cohort, we carried out a cross-sectional study using 29,775 participants (mean age 63 years, 53% female) with BP measurements and brain magnetic resonance imaging (MRI) data. …”

Algorithms for the capture and adjudication of prevalent and incident diabetes in UK Biobank by Eastwood, S, Mathur, R, Atkinson, M, Brophy, S, Sudlow, C, Flaig, R, De Lusignan, S, Allen, N, Chaturvedi, N

“…We developed algorithms to define prevalent and incident diabetes for UK Biobank. The algorithms will be implemented by UK Biobank and their results made available to researchers on request.…”

Epidemiology and the control of disease in China, with emphasis on the Chinese Biobank Study. by Li, L, Guo, Y, Chen, Z, Chen, J, Peto, R

“…As such, and on the basis of decades of cooperation and trust with the University of Oxford, the Chinese Biobank Study [Kadoorie Study of Chronic Disease in China (KSCDC)] was commenced in 2004. …”

Adiposity and chronic kidney disease: observations from UK Biobank by Zhu, P

“…</p> <p><b>Methods</b>: The study included 281,237 non-related White-British participants from UK Biobank to assess the relevance of central adiposity (waist-to-hip ratio, waist-to-height ratio, waist circumference and trunk fat percentage) and general adiposity (body-mass index [BMI], height-adjusted weight, hip circumference and body fat percentage) to CKD prevalence. …”

Metabolic profiling of MRI-measured liver fat in the UK Biobank by Gnatiuc Friedrichs, L, Trichia, E, Aguilar-Ramirez, D, Preiss, D

“…Metabolomic profiles of liver fat in the UK Biobank were investigated. <p><strong>Methods</strong></p> Regression models assessed the associations between 180 metabolites and proton density liver fat fraction (PDFF) measured 5 years later through magnetic resonance imaging, as the difference (in SD units) of each log metabolite measure with 1-SD higher PDFF among those without chronic disease and not taking statins, and by diabetes and cardiovascular diseases. …”

From single biobanks to international networks: developing e-governance by Kaye, J

Epidemiology and the control of disease in China, with emphasis on the Chinese Biobank Study by Li, L, Guo, Y, Chen, Z, Chen, J, Peto, R

UK Biobank: a globally important resource for cancer research. by Conroy, MC, Lacey, BWH, Bešević, J, Omiyale, W, Feng, Q, Effingham, M, Sellers, J, Sheard, S, Pancholi, M, Gregory, G, Busby, J, Collins, R, Allen, NE

“…UK Biobank is a large-scale prospective study with deep phenotyping and genomic data. …”

Sample, data use and protection in biobanking in Europe: legal issues. by Zika, E, Schulte In den Bäumen, T, Kaye, J, Brand, A, Ibarreta, D

“…The sharing of samples and data stored in biobanks for research has implications for donor privacy, but also raises questions on the regulation of research within Europe. …”

Metabolic syndrome biomarkers and prostate cancer risk in the UK Biobank by Monroy-Iglesias, MJ, Russell, B, Crawley, D, Allen, NE, Travis, R, Perez-Cornago, A, Van Hemelrijck, M, Beckmann, K

“…We investigated the association between metabolic syndrome (MetS) and its components and risk of prostate cancer (PCa) in a cohort of men enrolled in the UK Biobank. <br><br> Our study cohort included 220 622 PCa‐free men with baseline measurements of triglycerides (TG), HDL‐cholesterol (HDL), glycated haemoglobin (HbA1c), blood pressure (BP), and waist circumference (WC). …”

Women’s reproductive factors and incident cardiovascular disease in the UK Biobank by Peters, SAE, Woodward, M

“…We assessed the relationship between reproductive factors and incident CVD in the UK Biobank.</p><p> Methods: Between 2006-10, the UK Biobank recruited over 500,000 participants aged 40-69 years across the UK. …”

Meat intake and cancer risk: prospective analyses in UK Biobank by Knuppel, A, Papier, K, Fensom, G, Appleby, P, Schmidt, JA, Tong, Y, Wrightson, R, Key, T, Perez-Cornago, A

“…Methods We analyzed data from 474 996 participants (54% women) in UK Biobank. Participants were aged 37–73 years and cancer-free at baseline (2006–10). …”

Association of metabolic syndrome with neuroimaging and cognitive outcomes in the UK Biobank by Qureshi, D, Topiwala, A, Al Abid, S, Allen, N, Kuźma, E, Littlejohns, T

“…<p><strong> Research Design and Methods: </p></strong>We included 37,395 dementia-free adults from the UK Biobank. MetS was defined as ≥3 of the following components: elevated waistcircumference, triglycerides, blood-pressure, HbA1c, or reduced HDL-cholesterol. …”

The advantages of UK Biobank's open‐access strategy for health research by Conroy, M, Sellors, J, Effingham, M, Littlejohns, T, Boultwood, C, Gillions, R, Sudlow, C, Collins, R, Allen, N

“…Access to UK Biobank's unique breadth of phenotypic and genetic data has attracted researchers worldwide from across academia and industry. …”

From consent to institutions: designing adaptive governance for genomic biobanks. by O'Doherty, K, Burgess, M, Edwards, K, Gallagher, R, Hawkins, A, Kaye, J, McCaffrey, V, Winickoff, D

“…Biobanks are increasingly hailed as powerful tools to advance health research. …”

From single biobanks to international networks: developing e-governance. by Kaye, J

“…The future holds the possibility to link and network biobanks, existing biorepositories and reference databases for research purposes in ways that have not been possible before. …”